Posts tagged Biogen Idec

Biotech companies quickly entering generic market for biotech drugs known as biosimilars as federal officials push to contain health care spending. Momenta Pharmaceuticals, Biogen Idec,  and  Amgen have started separate ventures to develop, make, and  market generic biotech drugs.

Biotech companies quickly entering generic market for biotech drugs known as biosimilars as federal officials push to contain health care spending. Momenta Pharmaceuticals, Biogen Idec, and Amgen have started separate ventures to develop, make, and market generic biotech drugs.

Help on way for MS? Biogen Idec and Abbott Laboratories said Sunday a mid-stage study of their multiple sclerosis medicine daclizumab showed that the experimental drug worked better than placebo at preventing relapse of symptoms of the inflammatory disease.

Help on way for MS? Biogen Idec and Abbott Laboratories said Sunday a mid-stage study of their multiple sclerosis medicine daclizumab showed that the experimental drug worked better than placebo at preventing relapse of symptoms of the inflammatory disease.